Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Addict Med. 2015 Mar-Apr;9(2):130–135. doi: 10.1097/ADM.0000000000000107

Table 1.

Baseline clinical characteristics by genotype

A118G
(n=11)
A118A
(n=11)
95% CI of
difference
p
Age, years – mean (SEM) 39.5 (2.0) 40.7 (1.7) −5.71 – 3.35 0.69
Male - N (%) 6 (55%) 9 (82%) 0.02 – 2.47 0.36
Caucasian - N (%) 5 (45%) 11 (100%) 0.00 – 0.60 0.01
Days of MA use - mean (SD) 17.4 (8.3) 21.2 (9.7) −4.23 – 11.83 0.39
MA negative urine samples - N (%) 1 (9.1%) 4 (36%) −0.08 – 0.56 0.31
Smoking as primary route of administration - N (%) 9 (82%) 6 (55%) 0.40 – 48.8 0.36
AWQ withdrawal score (0–40) - mean (SEM) 15.7 (2.2) 12.4 (1.8) −9.16 – 2.56 0.53
ADHD diagnosis - N (%) 1 (9%) 0 (0%) 0.02 - ∞ 1